Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026)
Bio-Techne's (TECH) quarterly Other Accumulated Expenses came in at $2.1 million in Q1 2026, up 15.39% year-on-year from $1.8 million in Q1 2025, and up 32.57% quarter-over-quarter from $1.6 million in Q4 2025.
Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Bio-Techne's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 15.39% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 15.39% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 23.52% from the prior year.
- Other Accumulated Expenses grew to $2.1 million in Q1 2026 per TECH's latest filing, from $1.6 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $4.5 million in Q3 2025 and bottomed at $865000.0 in Q1 2023.
- The 5-year median for Other Accumulated Expenses is $2.1 million (2026), against an average of $2.5 million.
- Across the five-year window, Other Accumulated Expenses slumped 75.87% in 2022 and soared 240.92% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $1.3 million in 2022, then soared by 220.32% to $4.2 million in 2023, then plunged by 37.7% to $2.6 million in 2024, then slumped by 40.05% to $1.6 million in 2025, then surged by 32.57% to $2.1 million in 2026.
- Per Business Quant, the three latest TECH Other Accumulated Expenses figures stand at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.09 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 4.23 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 865,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 5.47 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 3.89 Mn |